UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

     -----------------------------------------------------------------------
                                    FORM 8-K
                                 CURRENT REPORT
     Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
     -----------------------------------------------------------------------

Date of Report (Date of earliest event reported): July 5, 2007
                        DOBI MEDICAL INTERNATIONAL, INC.
               (Exact Name of Registrant as Specified in Charter)

          Delaware                    0-32523                   98-0222710
(State or other jurisdiction    (Commission File Number)       (IRS Employer
      of incorporation)                                      Identification No.)

                1200 MacArthur Boulevard                            07430
                  Mahwah, New Jersey                             (Zip Code)
       (Address of principal executive offices)

       Registrant's telephone number, including area code: n/a
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:

|_| Written communications pursuant to Rule 425 under the Securities Act (17
    CFR 230.425)
|_| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
    240.14a-12)
|_| Pre-commencement communications pursuant to Rule 14d-2(b) under the
    Exchange Act (17 CFR 240.14d-2(b))
|_| Pre-commencement communications pursuant to Rule 13e-4 (c) under the
    Exchange Act (17 CFR 240.13e-4(c))

================================================================================

                           CURRENT REPORT ON FORM 8-K
                        DOBI MEDICAL INTERNATIONAL, INC.
                                  July 13, 2007

ITEM 8.01 OTHER EVENTS.

         (a) On July 5, 2007, the Securities and Exchange Commission staff
advised DOBI Medical International, Inc. that it had completed its investigation
and did not intend to recommend any enforcement action against the Company by
the Commission.


                                    SIGNATURE

         Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

                                       DOBI MEDICAL INTERNATIONAL, INC.

Date:  July 13, 2007                   By:   /s/ Michael R. Jorgensen
                                             -----------------------------------
                                             Michael R. Jorgensen
                                             Authorized Representative